Cholesterol Depletion Delocalizes Phosphatidylinositol Bisphosphate and Inhibits Hormone-stimulated Phosphatidylinositol Turnover*

  1. Linda J. Pike and
  2. Joanne M. Miller
  1. From the Department of Biochemistry and Molecular Biophysics, Washington University School of Medicine, St. Louis, Missouri 63110

    Abstract

    Caveolae and detergent-insoluble, glycosphingolipid-enriched domains (DIGs) are cholesterol-enriched membrane domains that have been implicated in signal transduction because a variety of signaling proteins as well as phosphatidylinositol bisphosphate (PtdInsP2) are compartmentalized in these domains. We report here that depletion of cellular cholesterol leads to the inhibition of epidermal growth factor- and bradykinin-stimulated PtdIns turnover in A431 cells. This is associated with the loss of compartmentalization of epidermal growth factor receptors, Gq, and PtdInsP2 in the low density membrane domains. Replacement of cellular cholesterol leads to the reorganization of signaling molecules in the low density domains and the reestablishment of hormone-stimulated PtdIns hydrolysis. Oxysterol derivatives show a variable ability to functionally replace the cholesterol in this system. These data are consistent with the hypothesis that localization of signaling proteins and lipids to cholesterol-enriched domains is required for the proper function of hormone-stimulated PtdIns turnover.

    Footnotes

    • * The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

    • To whom correspondence should be addressed: Dept. of Biochemistry and Molecular Biophysics, Washington University School of Medicine, 660 So. Euclid, Box 8231, St. Louis, MO 63110. Tel.: 314-362-9502; Fax: 314-362-7183; E-mail: pike{at}biochem.wustl.edu.

    • Abbreviations:
      DIGs

      detergent-insoluble, glycosphingolipid-enriched domains

      DMEM

      Dulbecco’s modified Eagle’s medium

      EGF

      epidermal growth factor

      MES

      4-morpholineethanesulfonic acid

      PDGF

      platelet-derived growth factor

      PtdIns

      phosphatidylinositol

      PtdInsP

      phosphatidylinositol monophosphate

      PtdInsP2

      phosphatidylinositol bisphosphate.

      • Received April 13, 1998.
      • Revision received June 6, 1998.
    « Previous | Next Article »Table of Contents
    • Advertisement
    • Advertisement
    Advertisement